Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07006454

Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache

This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–44 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foundation University College of Physical Therapy

Islamabad, 44000, Pakistan

Location status: Recruiting

Location contact

Hafiz Ali Bin Asim, MS-SPT

CONTACT

[email protected]

+923135088144

About this study

Participants will be recruited into their respective groups using a coin toss method.Cervicogenic headache will be assesed using International Classification of Headache Disorders, 3rd edition:

A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.

C- Evidence of cause of headache demonstrated by at least 2 of these:

  • headache has developed in temporal relation to the onset of the cervical disorder or lesion.
  • headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
  • cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
  • headache is abolished following anaesthetic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis.

CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Age 18 to 44 years old
  • Both male and female A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.

C- Evidence of cause of headache demonstrated by at least 2 of these:

  • headache has developed in temporal relation to the onset of the cervical disorder or lesion.
  • headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
  • cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
  • headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis

Exclusion criteria

  • 1- Tension-type headaches and migraine 2- History of Vertigo or Dizziness 3- Already taking manual therapy treatment 4- Prior surgery to the head and neck 5- Trauma

Treatment and study plan

Ventro-Cephalic Translatoric Glide

Procedure

Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

  • Patient sits on low chair with back straight and therapist stand facing the patient's right side.
  • Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra.
  • Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
  • Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.

Dorso-Caudal Translatoric Glide

Procedure

Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

  • Patient sits on low chair with back straight and therapist stand facing the patient's left side.
  • Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra.
  • Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
  • Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.

Primary outcomes

  1. Headache intensity

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks.

    It will be measured on a numeric pain rating scale where participant select number ranging from 0 to 10 based on pain intensity, with 0 representing no pain and 10 denotes extreme pain.

  2. Headache disability

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

    It will be measured using headache disability index (HDI) which is a 25 item self-rated questionnaire in which participants rate their headache disability by selecting an option from 1 to 3 (yes= 4 points, sometimes= 2 points, and No = 0 point) then sum of responses is used to get final score.

    Interpretation:

    10 to 28= mild disability 30 to 48= moderate disability 50 to 68= severe disability 72 or more= complete disability

  3. Quality of Life of patient

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

    It will be measured using headache impact test (HIT-6), this tool is used to measure impact of headache on ability to function, a 6 items self-rated questionnaire in which participant select an option from 1 to 5 (Never= 6 points, rarely= 8, sometimes= 10, very often= 11, always= 13) then sum of responses is used to get final score.

    Interpretation:

    60 or more= Very severe impact 56 to 59= Substantial impact 50 to 55= Some impact 49 or less= Little or no impact

  4. Headache Frequency

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

    It will be measured using medical diary, which is a self-reported measure in which the patient will be asked to report the number of headache days per week through a medical logbook, which will be recorded every day and night.

  5. Cervical range of motion

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

    It will be measured using CROM instrument a plastic frame device that is fastened to the head with help of Velcro-strap, it consist of 3 separate inclinometers that are fixed to frame (1 in sagittal plan which evaluates range of motion in flexion and extension, where 2nd in frontal plane which evaluates range of motion in side bending, and 3rd in horizontal plan which indicates range of motion in rotation)

  6. Cervical flexion rotation test

    Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

    It is used to evaluate impairment of cervical function as the diagnostic criterion of internation headache society (IHS) consist of subjective feathers which includes impairments at atlanto-axial motion segments which is assessed by cervical flexion rotation test.

Study contacts

Contact information is provided by the study sponsor or research team.

Aeysha Bibi, DPT

CONTACT

[email protected]

+923058766593

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 5, 2025
Registry last updated
Jun 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.